A comparative clinical study on efficacy of terbinafine and griseofulvin in patients with tinea corporis

G. Muthu Kavitha; M. Shanthi; M. S. Ahil

doi:10.18203/2319-2003.ijbcp20195783

Authors

G. Muthu Kavitha Department of Pharmacology, Government Theni Medical College, Theni, Tamil Nadu, India
M. Shanthi Department of Pharmacology, Madurai Medical College, Madurai, Tamil Nadu, India
M. S. Ahil Department of Pharmacology, Madurai Medical College, Madurai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20195783

Keywords:

Terbinafine, Griseofulvin, Tinea corporis

Abstract

Background: The objective of the present study was to compare the efficacy of terbinafine and griseofulvin in patients with tinea corporis in a tertiary care hospital, Madurai.

Methods: About 60 patients are selected from the outpatient department of Dermatology according to inclusion and exclusion criteria. They were divided into 2 groups of 30 patients each. Group 1 received tab. terbinafine 250 mg OD and group 2 received 250 mg BD for 4 weeks. All patients were investigated at baseline, end of 2^nd week and at end of 4 weeks. Effectiveness of both the drugs were determined by achieving clinical as well as mycological cure. The results were recorded, tabulated and analysed using student’s t test.

Results: Patients in group 1 showed higher clinical and mycological cure rate when compared with group 2.

Conclusions: Oral terbinafine is the effective antifungal agent in the treatment of extensive tinea corporis infection.

Metrics

Metrics Loading ...

References

Kanwar AJ, Dipankar De. Superficial Fungal Infections. In: Valia RG, Valia AR, eds. Textbook of Dermatology, 3rd ed. Mumbai: Bhalani Publishing House; 2008: 252-290.

Hay RJ. Ashbee HR. Mycology. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology. 8th ed. London: Wiley-Blackwell Publication; 2011;2(36):18-50.

Bennett JE. Antifungal agents. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman’s The Pharmacological basis of therapeutics. 12th ed. New York: McGraw Hill; 2011: 1571-1592.

Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G. Antifungal agents. Rang and Dale’s Pharmacology. 7th ed. Toronto: Elsevier; 2012: 649-653.

MacDonald E, Head ES. Introduction to fungal infections. In: Demis DJ, ed. Clinical dermatology. Philadelphia: JB Lippincott; 1989: section 17.1.

Hay RJ, Roberts SOB, Mackenzie DWR. Mycology. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of dermatology. Oxford: Blackwell Scientific Publications; 1992: 1128.

Jyothi N, Judith J, Nirmaladevi P. A Study on cutaneous infections among adults at the dermatology outpatient department in a rural tertiary care center. Tirunelveli J Med Sci. 2013;5:112-3.

Gupta AK. Systemic antifungal agents. In: Wolverton SE, eds. Comprehensive Dermatologic Drug Therapy, 3rd ed. USA: Elsevier publication; 2013: 98-119.

Chander J. Dermaptophytoses. In: Chander J (ed). Text book of Medical Mycology. 3rd edition. New Delhi: Mehta Offset Pvt Ltd; 2009: 122-142.

Venkatesan G, Singh AJAR, Murugesan AG, Janaki C, Shankar GS. Trichophyton rubrum– the predominant etiological agent in human dermatophytoses in Chennai, India. Afr J Microbiol. 2007;5:9-12.

Voravutinon V. Oral treatment of tineacorporis and tineacruris with terbinafine and griseofulvin: a randomized double blind comparative study. J Med Assoc Thai. 1993;76:388-93.

Beller M, Gessner BD. An outbreak of tinea corporis gladiatorum on a high school wrestling team. J Am Acad Dermatol. 1994;31:197-201.

Padhye AA, Summerbell RC. The Dermatophytes. In: Merz WG, Hay RJ, eds. Topley Wilson’s Medical Mycology, 10th ed. London: ASM Press; 2005: 220-238.